Stonehouse Jon P
Insider CIK 1385496 · BLCM Director · MTSR Director · BCRX President & CEO, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2026-08-31 | 2026-09-02 | 644 | $9.70 | $6.2K | 1,340,419 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2026-08-31 | 2026-09-02 | 644 | $9.70 | $6.2K | 1,340,419 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2026-06-11 | 2026-06-15 | 33,540 | — | $0 | 33,540 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2026-06-11 | 2026-06-15 | 15,294 | — | $0 | 1,339,775 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2026-05-29 | 2026-06-02 | 631 | $8.91 | $5.6K | 1,324,481 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2026-03-02 | 2026-03-03 | 305,995 | — | $0 | 0 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2026-03-02 | 2026-03-03 | 305,995 | $3.22 | $985.3K | 1,629,845 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | D To issuer | 2026-03-02 | 2026-03-03 | 305,995 | $8.64 | $2.64M | 1,323,850 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2026-02-27 | 2026-03-03 | 421 | $8.75 | $3.7K | 1,323,850 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2025-12-19 | 2025-12-23 | 61,793 | $7.41 | $457.9K | 1,323,429 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | G Gift | 2025-12-18 | 2025-12-19 | 10,000 | — | $0 | 40,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | G Gift | 2025-12-18 | 2025-12-19 | 10,000 | — | $0 | 40,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | G Gift | 2025-12-18 | 2025-12-19 | 20,000 | — | $0 | 1,385,222 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2025-12-12 | 2025-12-16 | 27,368 | $7.57 | $207.2K | 1,405,222 | SEC↗ |
| MTSR Metsera, Inc. | D To issuer deriv | 2025-11-13 | 2025-11-13 | 47,730 | — | $0 | 0 | SEC↗ |
| MTSR Metsera, Inc. | A Award deriv | 2025-11-13 | 2025-11-13 | 2,688 | — | $0 | 2,688 | SEC↗ |
| MTSR Metsera, Inc. | D To issuer | 2025-11-13 | 2025-11-13 | 2,688 | — | $0 | 0 | SEC↗ |
| MTSR Metsera, Inc. | A Award deriv | 2025-04-28 | 2025-04-30 | 47,730 | $19.81 | $945.5K | 47,730 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | G Gift | 2024-12-20 | 2024-12-23 | 20,000 | — | $0 | 1,429,109 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | G Gift | 2024-12-20 | 2024-12-23 | 10,000 | — | $0 | 30,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | G Gift | 2024-12-20 | 2024-12-23 | 10,000 | — | $0 | 30,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2024-12-19 | 2024-12-23 | 750,250 | — | $0 | 750,250 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2024-12-19 | 2024-12-23 | 14,010 | $7.39 | $103.5K | 1,449,109 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2024-12-19 | 2024-12-23 | 362,100 | — | $0 | 1,463,119 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2024-12-14 | 2024-12-17 | 27,525 | $7.53 | $207.3K | 1,101,019 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | P Buy | 2024-05-13 | 2024-05-15 | 30,000 | $5.55 | $166.5K | 1,127,770 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | G Gift | 2024-01-03 | 2024-01-04 | 10,000 | — | $0 | 20,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | G Gift | 2024-01-03 | 2024-01-04 | 10,000 | — | $0 | 20,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | G Gift | 2024-01-03 | 2024-01-04 | 20,000 | — | $0 | 1,094,770 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2023-12-19 | 2023-12-20 | 14,089 | $6.05 | $85.2K | 1,114,770 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2023-12-14 | 2023-12-18 | 595,000 | — | $0 | 595,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2023-12-14 | 2023-12-18 | 127,500 | — | $0 | 1,142,451 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2023-12-14 | 2023-12-18 | 13,592 | $6.43 | $87.4K | 1,128,859 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | G Gift | 2023-06-13 | 2023-06-15 | 25,000 | — | $0 | 1,014,794 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2023-03-21 | 2023-03-23 | 31,055 | — | $0 | 305,995 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2023-03-21 | 2023-03-23 | 31,055 | $3.22 | $100.0K | 1,039,794 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2023-02-01 | 2023-02-02 | 100,000 | — | $0 | 0 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2023-02-01 | 2023-02-02 | 100,000 | $10.38 | $1.04M | 1,008,739 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2023-02-01 | 2023-02-02 | 100,000 | $5.45 | $545.0K | 1,108,739 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | M Exercise | 2023-01-03 | 2023-01-05 | 121,452 | — | $0 | 204,086 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | G Gift | 2022-12-29 | 2023-02-02 | 10,000 | — | $0 | 1,008,739 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | G Gift | 2022-12-29 | 2023-02-02 | 5,000 | — | $0 | 10,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | G Gift | 2022-12-29 | 2023-02-02 | 5,000 | — | $0 | 10,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2022-12-19 | 2022-12-21 | 595,000 | — | $0 | 595,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2022-12-19 | 2022-12-21 | 127,500 | — | $0 | 1,015,230 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2022-12-15 | 2022-12-19 | 14,100 | $10.90 | $153.7K | 887,730 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2022-12-02 | 2022-12-02 | 82,656 | — | $0 | 0 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2022-12-02 | 2022-12-02 | 82,656 | $1.42 | $117.4K | 984,486 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2022-12-02 | 2022-12-02 | 82,656 | $12.80 | $1.06M | 901,830 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2022-12-01 | 2022-12-02 | 214,917 | — | $0 | 82,656 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2022-12-01 | 2022-12-02 | 214,917 | $13.00 | $2.79M | 901,830 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2022-12-01 | 2022-12-02 | 214,917 | $1.42 | $305.2K | 1,116,747 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | M Exercise | 2022-09-01 | 2023-01-04 | 60,580 | — | $0 | 82,634 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | M Exercise | 2022-09-01 | 2022-09-02 | 60,580 | — | $0 | 103,688 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2022-06-15 | 2022-06-16 | 15,000 | — | $0 | 15,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2022-01-11 | 2022-01-13 | 184,000 | — | $0 | 0 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2022-01-11 | 2022-01-13 | 184,000 | $15.04 | $2.77M | 901,602 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2022-01-11 | 2022-01-13 | 184,000 | $4.73 | $870.3K | 1,085,602 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | M Exercise deriv | 2022-01-04 | 2022-09-01 | 21,054 | — | $0 | 21,054 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | M Exercise | 2022-01-04 | 2022-09-01 | 21,054 | — | $0 | 22,054 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | M Exercise deriv | 2022-01-04 | 2022-01-06 | 21,504 | — | $0 | 0 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | M Exercise | 2022-01-04 | 2022-01-06 | 21,504 | — | $0 | 22,504 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2021-12-14 | 2021-12-16 | 574,500 | — | $0 | 574,500 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2021-12-14 | 2021-12-16 | 123,000 | — | $0 | 901,602 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | G Gift | 2021-09-01 | 2021-12-16 | 5,000 | — | $0 | 5,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | G Gift | 2021-09-01 | 2021-12-16 | 5,000 | — | $0 | 5,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | G Gift | 2021-09-01 | 2021-12-16 | 5,000 | — | $0 | 778,602 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | G Gift | 2021-09-01 | 2021-12-16 | 5,000 | — | $0 | 783,602 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2021-06-15 | 2021-07-07 | 6,500 | — | $0 | 6,500 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2021-01-04 | 2021-01-05 | 21,054 | — | $0 | 21,054 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2020-12-15 | 2020-12-17 | 134,278 | — | $0 | 1 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2020-12-15 | 2020-12-17 | 870,000 | — | $0 | 870,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2020-12-15 | 2020-12-17 | 134,278 | $8.32 | $1.12M | 784,086 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2020-12-15 | 2020-12-17 | 134,278 | $4.15 | $557.3K | 918,364 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2020-12-03 | 2020-12-07 | 157,250 | — | $0 | 157,250 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2020-12-03 | 2020-12-07 | 25,000 | — | $0 | 25,000 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2020-06-15 | 2020-06-16 | 6,500 | — | $0 | 6,500 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2020-05-13 | 2020-05-15 | 157,250 | — | $0 | 157,250 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2020-02-21 | 2020-02-25 | 27,140 | — | $0 | 27,140 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2020-02-14 | 2020-02-19 | 47,495 | — | $0 | 47,495 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2019-12-17 | 2019-12-19 | 314,500 | — | $0 | 314,500 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | P Buy | 2019-11-18 | 2019-11-18 | 50,000 | $1.45 | $72.5K | 778,086 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2019-06-13 | 2019-06-14 | 25,000 | — | $0 | 25,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2019-01-01 | 2019-01-03 | 3,568 | $8.07 | $28.8K | 724,106 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2018-12-20 | 2018-12-21 | 675,000 | — | $0 | 675,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2018-12-03 | 2018-12-06 | 80,000 | — | $0 | 0 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2018-12-03 | 2018-12-06 | 80,000 | $9.12 | $729.6K | 727,674 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2018-12-03 | 2018-12-06 | 80,000 | $1.20 | $96.0K | 807,674 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | P Buy | 2018-11-09 | 2018-11-13 | 10,000 | $4.56 | $45.6K | 10,000 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2018-06-14 | 2018-06-18 | 10,000 | — | $0 | 10,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2018-05-17 | 2018-05-21 | 70,427 | — | $0 | 297,573 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2018-05-17 | 2018-05-21 | 70,427 | $1.42 | $100.0K | 725,519 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2018-02-28 | 2018-03-02 | 56,949 | — | $0 | 0 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2018-02-28 | 2018-03-02 | 43,224 | $4.97 | $214.8K | 655,092 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2018-02-28 | 2018-03-02 | 56,949 | $3.26 | $185.7K | 698,316 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2018-01-20 | 2018-01-23 | 9,584 | $5.59 | $53.6K | 638,367 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2018-01-01 | 2018-01-03 | 2,716 | $4.91 | $13.3K | 647,951 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2017-12-20 | 2017-12-22 | 300,000 | — | $0 | 300,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2017-08-31 | 2017-09-05 | 40,710 | — | $0 | 40,710 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2017-06-14 | 2017-06-15 | 10,000 | — | $0 | 10,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2017-02-27 | 2017-03-01 | 500,000 | — | $0 | 500,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2017-01-20 | 2017-01-24 | 10,572 | $5.95 | $62.9K | 645,418 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2017-01-01 | 2017-01-03 | 8,595 | $6.33 | $54.4K | 655,990 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2016-06-15 | 2016-06-17 | 10,000 | — | $0 | 10,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2016-05-23 | 2016-05-25 | 337,050 | — | $0 | 337,050 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2016-03-01 | 2016-03-03 | 2,761 | $2.13 | $5.9K | 664,585 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2016-01-20 | 2016-01-21 | 24,096 | — | $0 | 134,279 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2016-01-20 | 2016-01-21 | 24,096 | $4.15 | $100.0K | 676,326 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2016-01-20 | 2016-01-22 | 10,624 | $7.55 | $80.2K | 665,702 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2016-01-01 | 2016-01-05 | 8,091 | $10.32 | $83.5K | 652,230 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2015-12-29 | 2015-12-31 | 162,950 | — | $0 | 162,950 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2015-07-15 | 2015-07-17 | 33,868 | — | $0 | 416,132 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2015-07-15 | 2015-07-17 | 33,868 | $11.81 | $400.0K | 684,737 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2015-07-15 | 2015-07-17 | 25,526 | $15.67 | $400.0K | 659,211 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2015-06-19 | 2015-06-22 | 20,000 | — | $0 | 80,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2015-06-19 | 2015-06-22 | 20,000 | $15.02 | $300.4K | 650,869 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2015-06-19 | 2015-06-22 | 20,000 | $1.20 | $24.0K | 670,869 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2015-06-17 | 2015-06-19 | 10,000 | — | $0 | 10,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2015-05-13 | 2015-06-16 | 25,000 | — | $0 | 25,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2015-03-01 | 2015-03-03 | 5,118 | $10.20 | $52.2K | 650,869 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2015-01-20 | 2015-01-22 | 10,608 | $11.17 | $118.5K | 654,280 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2015-01-01 | 2015-01-05 | 5,652 | $12.16 | $68.7K | 664,888 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2015-01-01 | 2015-01-05 | 28,400 | — | $0 | 670,540 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2014-12-19 | 2014-12-23 | 25,000 | — | $0 | 25,000 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2014-12-17 | 2014-12-19 | 23,529 | — | $0 | 23,529 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2014-05-26 | 2014-05-28 | 25,000 | — | $0 | 25,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2014-05-09 | 2014-05-12 | 3,801 | — | $0 | 56,949 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2014-05-09 | 2014-05-12 | 26,991 | — | $0 | 116,809 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2014-05-09 | 2014-05-12 | 9,625 | — | $0 | 158,375 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2014-05-09 | 2014-05-12 | 3,801 | $3.26 | $12.4K | 634,043 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2014-05-09 | 2014-05-12 | 1,610 | $7.70 | $12.4K | 632,433 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2014-05-09 | 2014-05-12 | 9,625 | $4.15 | $39.9K | 645,633 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2014-05-09 | 2014-05-12 | 23,416 | $7.70 | $180.3K | 636,008 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2014-05-09 | 2014-05-12 | 26,991 | $6.68 | $180.3K | 659,424 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2014-05-09 | 2014-05-12 | 5,188 | $7.70 | $39.9K | 640,445 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2014-03-01 | 2014-03-07 | 5,118 | $11.69 | $59.8K | 630,242 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2014-01-20 | 2014-02-04 | 84,000 | — | $0 | 84,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2014-01-20 | 2014-02-04 | 128,000 | — | $0 | 632,360 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2014-01-01 | 2014-01-03 | 8,592 | $7.60 | $65.3K | 504,360 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2013-05-23 | 2013-05-28 | 179,600 | — | $0 | 100,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2013-05-23 | 2013-05-28 | 179,600 | $1.20 | $215.5K | 509,952 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2013-03-01 | 2013-03-06 | 5,967 | $1.19 | $7.1K | 331,258 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2013-01-31 | 2013-03-14 | 3,000 | $1.38 | $4.1K | 340,225 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2013-01-01 | 2013-04-12 | 31,300 | — | $0 | 333,319 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2013-01-01 | 2013-04-12 | 31,300 | — | $0 | 302,019 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2013-01-01 | 2013-01-07 | 184,000 | — | $0 | 184,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2013-01-01 | 2013-01-07 | 184,000 | — | $0 | 184,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2013-01-01 | 2013-01-07 | 33,253 | — | $0 | 303,972 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2013-01-01 | 2013-01-07 | 33,253 | — | $0 | 337,225 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2012-03-15 | 2012-03-19 | 13,612 | $5.23 | $71.2K | 267,719 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2012-03-15 | 2012-03-19 | 41,947 | — | $0 | 281,331 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2012-03-02 | 2012-03-05 | 2,721 | $4.78 | $13.0K | 239,384 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2012-03-01 | 2012-03-05 | 184,000 | $4.73 | $870.3K | 184,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2012-03-01 | 2012-03-05 | 33,253 | — | $0 | 242,105 | SEC↗ |